Suppr超能文献

婴幼儿不明原因发热的管理

Management of fever without source in infants and children.

作者信息

Baraff L J

机构信息

Department of Pediatrics and Emergency Medicine, University of California, Los Angeles Emergency Medicine Center, Los Angeles, CA, USA.

出版信息

Ann Emerg Med. 2000 Dec;36(6):602-14. doi: 10.1067/mem.2000.110820.

Abstract

Twenty percent of febrile children have fever without an apparent source of infection after history and physical examination. Of these, a small proportion may have an occult bacterial infection, including bacteremia, urinary tract infection (UTI), occult pneumonia, or, rarely, early bacterial meningitis. Febrile infants and young children have, by tradition, been arbitrarily assigned to different management strategies by age group: neonates (birth to 28 days), young infants (29 to 90 days), and older infants and young children (3 to 36 months). Infants younger than 3 months are often managed by using low-risk criteria, such as the Rochester Criteria or Philadelphia Criteria. The purpose of these criteria is to reduce the number of infants hospitalized unnecessarily and to identify infants who may be managed as outpatients by using clinical and laboratory criteria. In children with fever without source (FWS), occult UTIs occur in 3% to 4% of boys younger than 1 year and 8% to 9% of girls younger than 2 years of age. Most UTIs in boys occur in those who are uncircumcised. Occult pneumococcal bacteremia occurs in approximately 3% of children younger than 3 years with FWS with a temperature of 39.0 degrees C (102.2 degrees F) or greater and in approximately 10% of children with FWS with a temperature of 39.5 degrees C (103.1 degrees F) or greater and a WBC count of 15, 000/mm(3) or greater. The risk of a child with occult pneumococcal bacteremia later having meningitis is approximately 3%. The new conjugate pneumococcal vaccine (7 serogroups) has an efficacy of 90% for reducing invasive infections of Streptococcus pneumoniae. The widespread use of this vaccine will make the use of WBC counts and blood cultures and empiric antibiotic treatment of children with FWS who have received this vaccine obsolete.

摘要

经病史询问和体格检查后,20%的发热儿童无明显感染源。其中一小部分可能患有隐匿性细菌感染,包括菌血症、尿路感染(UTI)、隐匿性肺炎,或罕见的早期细菌性脑膜炎。传统上,发热婴幼儿根据年龄组被随意分配到不同的管理策略:新生儿(出生至28天)、小婴儿(29至90天)以及较大婴儿和幼儿(3至36个月)。3个月以下的婴儿通常采用低风险标准进行管理,如罗切斯特标准或费城标准。这些标准的目的是减少不必要住院的婴儿数量,并通过临床和实验室标准识别可作为门诊患者管理的婴儿。在无感染源发热(FWS)儿童中,1岁以下男孩隐匿性UTI的发生率为3%至4%,2岁以下女孩为8%至9%。男孩的大多数UTI发生在未行包皮环切术者。体温39.0℃(102.2℉)或更高的3岁以下FWS儿童中,隐匿性肺炎球菌菌血症的发生率约为3%;体温39.5℃(103.1℉)或更高且白细胞计数为15,000/mm³或更高的FWS儿童中,发生率约为10%。隐匿性肺炎球菌菌血症儿童日后发生脑膜炎的风险约为3%。新型结合肺炎球菌疫苗(7个血清型)预防肺炎链球菌侵袭性感染的效力为90%。这种疫苗的广泛使用将使对已接种该疫苗的FWS儿童进行白细胞计数、血培养及经验性抗生素治疗变得过时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验